Medication info

SITD-M tablet 25 milligrams (Sitagliptin hydrochloride monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.35mg / 1 tablet
Manufacturer / importer
Dongwha Pharmaceutical Co., Ltd.
Appearance
Pink, round, biconvex film-coated tablets
Packaging
28 tablets/box [14 tablets/PTP X 2]
Approval status
Active

MFDS item code 202101983 · Approved 2021.03.03

Summary

Main use
Improvement of glycemic control in patients with type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dose adjustment is required according to renal function, assessment of renal function is recommended before and periodically during treatment with this medicine. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Dongwha Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in patients with type 2 diabetes mellitus

  • Difficulty in blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used to improve blood sugar control in patients with type 2 diabetes. It is administered as an adjunct to dietary and exercise therapy and may be used alone in patients who have difficulty achieving initial blood sugar control. If the patient has not previously used diabetes medications or if blood sugar control is insufficient with monotherapy, it can be taken in combination with metformin. Additionally, this medication can be used in combination with sulfonylureas, metformin, thiazolidinediones, or insulin in patients who are not achieving adequate blood sugar control with these medications alone to enhance therapeutic efficacy. In cases of difficulty achieving blood sugar control even with combination therapy, this medication can be added to assist in blood sugar control. Therefore, this medication effectively improves blood sugar control in type 2 diabetes.

How to take

Adult dose

Administer 100 mg once daily as monotherapy or combination therapy; the maximum daily dose is 100 mg. This medicine may be taken with or without food. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions, 5. General Precautions). Patients with renal impairment Because dose adjustment is required according to renal function, assessment of renal function is recommended before and periodically during treatment with this medicine. 1. No dose adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is necessary in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily in patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This medicine may be administered regardless of the timing of dialysis.

Precautions

This medication may cause severe allergic reactions in some patients. Such reactions can occur within the first 3 months after starting the medication, so careful monitoring is necessary. Moreover, during treatment with this medication, pancreatitis (inflammation of the pancreas) may occur, so if symptoms such as abdominal pain or vomiting appear, consultation with a physician is required immediately. Patients with type 1 diabetes or diabetic ketoacidosis should not use this medication, nor should patients with a history of allergic reactions to this medication or its components. Patients with impaired renal function should adjust the dosage of this medication, following their physician's instructions. During the treatment with this medication, side effects such as cold symptoms, headache, indigestion, diarrhea, and dizziness may occur, and patients may also experience hypoglycemia, making thorough blood sugar management essential. Particularly, caution is needed as the risk of hypoglycemia may increase when used in combination with insulin or sulfonylureas. This medication has been reported to seldom cause serious side effects such as arthralgia or blistering conditions resembling bullous pemphigoid, and patients should report any such symptoms to their physician immediately. It is recommended that women who are pregnant or breastfeeding avoid using this medication, and safety and efficacy have not been established for children or adolescents under 18 years of age. Elderly patients should be monitored for reduced renal function, necessitating dosage adjustments and regular renal function checks. In case of overdose, general treatment should be administered, and blood dialysis may be considered if necessary. Finally, this medication does not significantly interact when taken with several other medications, but interactions may occur with some drugs, so it is crucial to consult a physician or pharmacist regarding any other medications being taken.

Side effects

  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • acute pancreatitis
  • hypoglycemia
  • nasopharyngitis
  • upper respiratory infection
  • headache
  • diarrhea
  • abdominal pain
Show 28 more
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute kidney failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, and the storage temperature must be maintained between 1 and 30 degrees Celsius at room temperature. Storing it in this manner will help maintain its efficacy for longer.

Appearance and packaging

Appearance

Pink, round, biconvex film-coated tablets

Package unit

28 tablets/box [14 tablets/PTP X 2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.